News
On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic ...
The appointment of a vocal critic of expedited approvals of vaccines, Vinay Prasad, to run the FDA’s office responsible for ...
The gravity of these decisions calls for a degree of humility on the part of an FDA leader. And that’s the rub with Vinay ...
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
Moderna is counting on revenue from newer mRNA vaccines, including a next generation Covid shot, to make up for falling sales ...
The appointment, announced May 6 by FDA Commissioner Dr. Marty Makary, places Prasad at the helm of one ... is precisely what the agency needs. “Vinay is willing to ask tough questions about ...
At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...
6d
Clinical Trials Arena on MSNNavigating the FDA’s accelerated approval pathways for oncology drugsAt CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...
The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...
The US Food and Drug Administration (FDA) is set to sharply restrict vaccine availability to millions of Americans without a ...
A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results